Stock A043150 VALUE ADDED TECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Value Added Technology Co., Ltd.

Equities

A043150

KR7043150002

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-28 pm EDT 		5-day change 1st Jan Change
29,800 KRW +0.68% Intraday chart for Value Added Technology Co., Ltd. +1.36% -10.38%
2023 Value Added Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
2017 Value Added Technology Co., Ltd. acquired 51.13% stake in Vatech America, Inc. from Vatech E-Woo Holdings Limited for KRW 11.5 billion. CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 433,744 333,478 525,098 487,220 493,904 442,657 - -
Enterprise Value (EV) 2 424.3 274.7 441.5 424.3 493.9 329.2 279.6 442.7
P/E ratio 12.8 x -13.8 x 10.2 x 6.46 x 9.55 x 6.56 x 5.97 x -
Yield 0.34% 0.45% 0.28% 0.3% - 0.34% 0.34% -
Capitalization / Revenue 1.6 x 1.36 x 1.55 x 1.23 x 1.28 x 1.05 x 0.96 x 0.91 x
EV / Revenue 1.56 x 1.12 x 1.3 x 1.07 x 1.28 x 0.78 x 0.61 x 0.91 x
EV / EBITDA 8.41 x 6.48 x 5.86 x 4.65 x 6.28 x 3.59 x 2.77 x -
EV / FCF 12.1 x 5.96 x 13.8 x 22.3 x - 6.38 x 4.5 x -
FCF Yield 8.3% 16.8% 7.25% 4.48% - 15.7% 22.2% -
Price to Book 1.75 x 1.5 x 1.92 x 1.39 x - 0.95 x 0.82 x -
Nbr of stocks (in thousands) 14,854 14,854 14,854 14,854 14,854 14,854 - -
Reference price 3 29,200 22,450 35,350 32,800 33,250 29,800 29,800 29,800
Announcement Date 2/25/20 2/1/21 2/7/22 2/1/23 2/5/24 - - -
1KRW in Million2KRW in Billions3KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 271.7 244.5 339 394.9 384.9 421 459.6 484.2
EBITDA 1 50.46 42.42 75.39 91.22 78.66 91.69 101.1 -
EBIT 1 42.87 32.62 65.53 80.35 64.04 77.29 86.26 83.8
Operating Margin 15.78% 13.34% 19.33% 20.35% 16.64% 18.36% 18.77% 17.31%
Earnings before Tax (EBT) 1 48.44 -23.12 74.23 98.4 66.74 85.48 94.69 -
Net income 1 34.28 -21.78 51.24 75.84 52.97 66.1 74.19 -
Net margin 12.62% -8.91% 15.11% 19.2% 13.76% 15.7% 16.14% -
EPS 2 2,281 -1,630 3,449 5,079 3,483 4,544 4,995 -
Free Cash Flow 3 35,210 46,099 31,992 19,028 - 51,600 62,080 -
FCF margin 12,958.85% 18,851.47% 9,437.79% 4,818.13% - 12,257.02% 13,507.82% -
FCF Conversion (EBITDA) 69,772.97% 108,673.1% 42,434.43% 20,860.25% - 56,279.22% 61,404.55% -
FCF Conversion (Net income) 102,705.77% - 62,441.75% 25,089.8% - 78,063.54% 83,681.88% -
Dividend per Share 2 100.0 100.0 100.0 100.0 - 100.0 100.0 -
Announcement Date 2/25/20 2/1/21 2/7/22 2/1/23 2/5/24 - - -
1KRW in Billions2KRW3KRW in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 83.19 95.83 85.96 106.7 99.1 103.3 90.95 102 87.66 106.7 96.78 109.5 99.47 117.2
EBITDA - - - - - - - - - - - - - -
EBIT 1 17.8 14.73 15.2 23.02 19.53 21.89 14.05 19.75 16.95 14.56 16.65 21.57 17.93 18.83
Operating Margin 21.4% 15.37% 17.68% 21.58% 19.71% 21.18% 15.45% 19.38% 19.34% 13.64% 17.2% 19.69% 18.03% 16.07%
Earnings before Tax (EBT) 1 23 14.18 19.08 29.71 29.11 19.67 18.24 22.36 20.16 7.928 20.65 24.3 20 23.2
Net income 1 17.35 7.895 14.3 22.68 23.34 15.13 14.41 16.91 17.63 4.705 15.7 19.1 20.5 14.7
Net margin 20.85% 8.24% 16.64% 21.27% 23.55% 14.64% 15.84% 16.59% 20.11% 4.41% 16.22% 17.44% 20.61% 12.54%
EPS 1,168 531.0 - - - - 970.0 - - - - - - -
Dividend per Share - - - - - - - - - - - - - -
Announcement Date 11/9/21 2/7/22 5/3/22 8/8/22 11/8/22 2/1/23 5/11/23 8/8/23 11/8/23 2/5/24 - - - -
1KRW in Billions
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 9.43 58.7 83.6 63 - 113 163 -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 2 35,210 46,099 31,992 19,028 - 51,600 62,080 -
ROE (net income / shareholders' equity) 14.5% -9.02% 23.6% 23.5% 13.6% 15.2% 14.6% -
ROA (Net income/ Total Assets) 9.62% -5.89% 13.2% 16.5% - 11.1% 11% -
Assets 1 356.4 369.9 386.9 459.2 - 593.7 673.4 -
Book Value Per Share 3 16,730 14,979 18,394 23,514 - 31,404 36,533 -
Cash Flow per Share 3 2,738 3,443 2,971 7,347 - 5,577 6,391 -
Capex 1 5.47 5.04 12.1 14.3 - 19.5 19.8 -
Capex / Sales 2.01% 2.06% 3.58% 3.62% - 4.64% 4.3% -
Announcement Date 2/25/20 2/1/21 2/7/22 2/1/23 2/5/24 - - -
1KRW in Billions2KRW in Million3KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Value Added Technology Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
29,800 KRW
Average target price
43,857 KRW
Spread / Average Target
+47.17%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
VALUE ADDED TECHNOLOGY CO., LTD. Stock Value Added Technology Co., Ltd.
-10.38% 319M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.61% 219B
DANAHER CORPORATION Stock Danaher Corporation
+7.00% 183B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+10.93% 133B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+25.38% 108B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+0.27% 63.06B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+12.90% 52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+3.96% 48.2B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
+0.29% 40.37B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+13.66% 39.35B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. A043150 Stock
  4. Financials Value Added Technology Co., Ltd.